Get it on Google Play

Remdesivir Shortage in India : Reasons

Remdesivir :

Remdesivir is an injectable anti-virus. It is injected to prevent replication of the virus.

  • The Remdesivir was created in 2014.
  • It was manufactured on large scale to treat Ebola. Later it was used to treat SARS and MERS.
  • Recently, after the COVID-19 crisis, it has been repurposed for COVID-19 treatment
  • The shortage of Remdesivir is increasing day by day mainly because of rising COVID-19 cases.
  • It is also increasing due to manufacturing and supply issues.
  • Madhya Pradesh complained that it has received only half of its requirements.
  • Around 70% of the total production of Remdesivir in the country is diverted to Maharashtra.
  • COVID-19 infections began rising exponentially after the double mutant variety started spreading in the country.
  • This began around February 2021.
  • However, the manufacturing resumed only by the end of March 2021.
  • This is mainly because Remdesivir requires twenty-five different raw materials in its production.
  • The supply chain in India was not strong enough to collect all the raw materials in a short span of time.
  • The cycle from production to transportation of Remdesivir takes 20-25 days.
  • Thus, the supply chain of the country must strengthen more to avoid similar crises in the future.

Leave a Reply

Your email address will not be published. Required fields are marked *